The General Hospital Corporation

Boston, MA, United States

1

Total Recalls

0

Class I Recalls

0

Ongoing Recalls

Recalls by The General Hospital Corporation

FDA Drug Class II Terminated

Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50

February 17, 2021 The General Hospital Corporation 50 mL vial units